NCT03489161View on ClinicalTrials.gov

Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

August 1, 2018

Primary Completion Date

August 28, 2018

Study Completion Date

August 28, 2018

Conditions
Drug OverdoseOpioid WithdrawalOpioid-use Disorder
Interventions
DRUG

Buprenorphine

buprenorphine/naloxone 4mg/1 mg for Clinical Opioid Withdrawal Scale (COWS) scores between 8 and 12, or 8mg/2mg S/L ≥ 12 by the sublingual route

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT03489161 - Feasibility of the Utilization of Buprenorphine in the Emergency Room to Treat Clinical Opioid Withdrawal | Biotech Hunter | Biotech Hunter